Next Article in Journal
Recent Advances in the Tumour Biology of the GPI-Anchored Carcinoembryonic Antigen Family Members CEACAM5 and CEACAM6
Previous Article in Journal
Addition of Lenalidomide to Melphalan in the Treatment of Newly Diagnosed Multiple Myeloma: The National Cancer Institute of Canada Clinical Trials Group MY.11 Trial
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 14
Issue 2
10.3747/co.2007.108
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Hepatocyte Growth Factor and the Hepatocyte Growth Factor Receptor Signalling Complex as Targets in Cancer Therapies

by
W.G. Jiang
Metastasis and Angiogenesis Research Group, Wales College of Medicine, Cardiff University, Cardiff CF14 4XN, UK
Curr. Oncol. 2007, 14(2), 66-69; https://doi.org/10.3747/co.2007.108
Submission received: 2 January 2007 / Revised: 1 February 2007 / Accepted: 1 March 2007 / Published: 1 April 2007

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Since its discovery in the late 1980s [...]
Keywords: hepatocyte growth factor; cMet; targeting; cancer treatment hepatocyte growth factor; cMet; targeting; cancer treatment

Share and Cite

MDPI and ACS Style

Jiang, W.G. Hepatocyte Growth Factor and the Hepatocyte Growth Factor Receptor Signalling Complex as Targets in Cancer Therapies. Curr. Oncol. 2007, 14, 66-69. https://doi.org/10.3747/co.2007.108

AMA Style

Jiang WG. Hepatocyte Growth Factor and the Hepatocyte Growth Factor Receptor Signalling Complex as Targets in Cancer Therapies. Current Oncology. 2007; 14(2):66-69. https://doi.org/10.3747/co.2007.108

Chicago/Turabian Style

Jiang, W.G. 2007. "Hepatocyte Growth Factor and the Hepatocyte Growth Factor Receptor Signalling Complex as Targets in Cancer Therapies" Current Oncology 14, no. 2: 66-69. https://doi.org/10.3747/co.2007.108

Article Metrics

Back to TopTop